Retrospective study of distributions of FcGRIIa-131 and FcGRIIIa-158 polymorphisms and clinical response to cetuximab in metastatic colorectal cancer (mCRC)

ABSTRACT: Primary outcome(s): Comparisons according to FcGR polymorphisms for progression-free survival

DISEASE(S): Colorectal Cancer

PROVIDER: 2619688 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR